How Much Did Nusano Raise?
Funding & Key Investors

Nusano, a privately held physics company, has secured $156M in total capital, with its most recent funding round bringing in $115M through a major strategic investment. This significant backing underscores the company's pivotal role in addressing supply stability and innovation within the rapidly expanding medical radioisotopes market, as well as serving industrial and commercial sectors reliant on consistent access to high-quality radioisotopes.

What is Nusano?

Nusano
ManufacturingChemicals & Related Products

Nusano operates at the intersection of physics and healthcare, focusing on the critical and often undersupplied market for medical radioisotopes. The company is dedicated to enhancing supply chain reliability and fostering innovation in this vital sector. Beyond medical applications, Nusano also caters to industrial and commercial clients who depend on a steady provision of premium radioisotopes for their product development and manufacturing processes. The company's commitment to stability and advancement positions it as a key player in a market with significant growth potential.

How much funding has Nusano raised?

Nusano has raised a total of $156M across 2 funding rounds:

2018

Series A

$41M

2024

Series C

$115M

Series A (2018): $41M, investors not publicly disclosed

Series C (2024): $115M led by Verily, The Wasatch Group, and S32

Key Investors in Nusano

Verily

Verily Life Sciences LLC is a subsidiary of Alphabet Inc., focusing on improving health outcomes through data-driven research and digital health solutions, developing software platforms and analytics tools for large-scale biomedical data.

The Wasatch Group

The Wasatch Group is an investment and development company with a focus on real estate and related ventures, known for its strategic investments in various sectors.

S32

S32 (formerly known as Three Point Capital) is a venture capital firm that invests in early-stage companies, particularly those in the healthcare and technology sectors, aiming to support disruptive innovation.

What's next for Nusano?

The recent major strategic investment signifies a strong vote of confidence in Nusano's business model and its capacity for scaling operations. This enterprise-level funding is expected to accelerate Nusano's efforts in expanding its production capabilities, enhancing its technological infrastructure, and potentially broadening its market reach. The company is poised to further solidify its position as a leader in the medical radioisotopes sector, driving innovation and ensuring a stable supply for critical applications.

See full Nusano company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Industrial Machinery & EquipmentManufacturing
Chemicals & Related ProductsManufacturingBusiness ServicesResearch & Development
Industrial Machinery & EquipmentManufacturingElectronics
Industrial Machinery & EquipmentManufacturingCivil Engineering ConstructionConstruction ManagementConstruction

Frequently Asked Questions Regarding Nusano Financial Insights

What are the most recent funding rounds that Nusano has completed, and what were the funding rounds?
Nusano has recently completed 2 funding rounds: Series C on Oct 1, 2024, Series A on Oct 24, 2018.
What is the total amount of funding Nusano has raised to date?
Nusano has raised a total of $156M in funding to date.
How many funding rounds has Nusano completed?
Nusano has completed 2 funding rounds.
How much funding did Nusano raise in its most recent funding round?
Nusano raised $115M in its most recent funding round.
Who are the lead investors in Nusano's latest funding round?
The lead investor in Nusano's latest funding round was Verily. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Nusano's history?
The largest funding round in Nusano's history was $115M.
See more information about Nusano